|
产品描述
|
Certainly! Here's a structured approach to supplement and improve the product information for the Anti-Amyloid Oligomers (A11) Antibody:
---
Anti-Amyloid Oligomers (A11) Antibody
Storage
- Temperature: Store at -20°C or lower for long-term storage.
- Avoid Freeze/Thaw Cycles: Minimize repeated freeze-thaw cycles to maintain antibody integrity.
- Short-term Storage: If using within a month, store at 4°C.
- Preservatives: Ensure that any preservatives or stabilizers are compatible with your storage conditions to prevent degradation.
Product Description
- Composition: The A11 antibody specifically targets amyloid oligomers, which are precursors to fibrillar amyloid deposits.
- Formulation: Supplied as a liquid solution or lyophilized powder. It may include a buffer for stabilization.
- Concentration: Typically provided at a concentration suitable for direct use in applications such as Western blotting and immunohistochemistry.
- Species Reactivity: Recognizes amyloid oligomers across various species, including human, mouse, and rat.
- Clone Information: Monoclonal antibody generated from hybridoma technology for high specificity.
Key Features
- High Specificity: Exclusively binds to amyloid oligomers and not monomers or fibrils.
- Versatility: Suitable for use in various assay platforms, including ELISA, immunostaining, and flow cytometry.
- Validated: Rigorous testing ensures consistent performance across applications.
- Purity: Highly purified to ensure minimal non-specific binding.
What's Included
- Antibody Solution: Provided in a vial with a specified volume and concentration.
- Data Sheet: Comprehensive product information, including proven protocols and applications.
- Certificate of Analysis: Verification of antibody quality and performance metrics.
- User Manual: Instructions for optimal use, including dilution factors and recommended conditions.
Applications
- Research on Neurodegenerative Diseases: Particularly useful in studying Alzheimer's disease and other conditions characterized by amyloid deposits.
- Diagnostic Development: Potential use in developing assays for early detection of amyloid-related pathologies.
- Therapeutic Research: Exploration of the role of amyloid oligomers in disease progression and testing therapeutic interventions.
- Biomarker Identification: Identification of amyloid oligomers as biomarkers for disease states.
---
Feel free to adapt this template to match your specific product details and branding requirements.
|